| Literature DB >> 15902953 |
Stephen E To1, Robert A Zepf, Alisa G Woods.
Abstract
Depression as a medical disorder increasingly is being recognized and treated. The mood of an individual with major depression is often described as sad, hopeless, or discouraged, and there are many physical symptoms associated with depression. Pharmacologic treatments for depression have advanced greatly since the development of the first therapies, monoamine oxidase inhibitors (MAOIs). Many medications, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs), currently are available to help combat this health problem. Newer medications have eliminated many of the side effects associated with older therapies, and treatments in development are designed with the goal of further improving on efficacy while eliminating side effects.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15902953
Source DB: PubMed Journal: J Neurosci Nurs ISSN: 0888-0395 Impact factor: 1.230